期刊文献+

Functional proteomics of adenosine triphosphatase system in the rat striatum during aging

Functional proteomics of adenosine triphosphatase system in the rat striatum during aging
暂未订购
导出
摘要 The maximum rates of adenosine triphosphatase (ATPase) systems related to energy consumption were systematically evaluated in synaptic plasma membranes isolated from the striata of male Wistar rats aged 2, 6, 12, 18, and 24 months, because of their key role in presynaptic nerve ending homeostasis. The following enzyme activities were evaluated: sodium-potassium-magnesium adenosine triphosphatase (Na^+, K^+, Mg^2+-ATPase); ouabain-insensitive magnesium adenosine triphosphatase (Mg^2+-ATPase); sodium-potassium adenosine triphosphatase (Na^+, K^+-ATPase); direct magnesium adenosine triphosphatase (Mg^2+-ATPase); calcium-magnesium adenosine triphosphatase (Ca^2+, Mg^2+-ATPase); and acetylcholinesterase. The results showed that Na~, K+-ATPase decreased at 18 and 24 months, Ca^2+, Mg^2+-ATPase and acetylcholinesterase decreased from 6 months, while Mg^2+-ATPase was unmodified. Therefore, ATPases vary independently during aging, suggesting that the ATPase enzyme systems are of neuropathological and pharmacological importance. This could be considered as an experimental model to study regeneration processes, because of the age-dependent modifications of specific synaptic plasma membranes. ATPases cause selective changes in some cerebral functions, especially bioenergetic systems. This could be of physiopathological significance, particularly in many central nervous system diseases, where, during regenerative processes, energy availability is essential. The maximum rates of adenosine triphosphatase (ATPase) systems related to energy consumption were systematically evaluated in synaptic plasma membranes isolated from the striata of male Wistar rats aged 2, 6, 12, 18, and 24 months, because of their key role in presynaptic nerve ending homeostasis. The following enzyme activities were evaluated: sodium-potassium-magnesium adenosine triphosphatase (Na^+, K^+, Mg^2+-ATPase); ouabain-insensitive magnesium adenosine triphosphatase (Mg^2+-ATPase); sodium-potassium adenosine triphosphatase (Na^+, K^+-ATPase); direct magnesium adenosine triphosphatase (Mg^2+-ATPase); calcium-magnesium adenosine triphosphatase (Ca^2+, Mg^2+-ATPase); and acetylcholinesterase. The results showed that Na~, K+-ATPase decreased at 18 and 24 months, Ca^2+, Mg^2+-ATPase and acetylcholinesterase decreased from 6 months, while Mg^2+-ATPase was unmodified. Therefore, ATPases vary independently during aging, suggesting that the ATPase enzyme systems are of neuropathological and pharmacological importance. This could be considered as an experimental model to study regeneration processes, because of the age-dependent modifications of specific synaptic plasma membranes. ATPases cause selective changes in some cerebral functions, especially bioenergetic systems. This could be of physiopathological significance, particularly in many central nervous system diseases, where, during regenerative processes, energy availability is essential.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2012年第1期6-12,共7页 中国神经再生研究(英文版)
关键词 ATPASE synaptic plasma membranes AGING STRIATUM functional proteomics ATPase synaptic plasma membranes aging striatum functional proteomics
  • 相关文献

参考文献60

  • 1Villa RF, Gorini A. Enzyme mitochondrial systems during aging: pharmacological implications. Neuro Chem (Life Sci Adv). 1991;10:49-59.
  • 2Villa RF, Gorini A. Action of L-acetylcarnitine on different cerebral mitochondrial populations from hippocampus and striatum during aging. Neurochem Res. 1991;16:1125-1132.
  • 3Villa RF, Gorini A, Hoyer S. Differentiated effect of aging of Krebs cycle, electron transfer complexes and glutamate metabolism of non-synaptic and intra-synaptic mitochondria from cerebral corte J Neural Transm. 2006;113:1659-1670.
  • 4Villa RF, Gorini A, Hoyer S. Effect of ageing and ischemia on enzymatic activities linked to Krebs' cycle, electron transfer chain glutamate and amino acids metabolism of free and intra-synaptic mitochondria of cerebral cortex. Neurochem Res. 2009;34: 2102-2116.
  • 5Beal MF. Bioenergetic approaches for neuroprotection in Parkinson’s disease. Ann Neurol. 2003;53:S39-47.
  • 6Villa RF, Arnaboldi R, Ghigini B, et al. Mitochondrial factors involved in Parknson's disease by MPTP toxicity in Macaca fascicularis and drug effect. Neurochem Res. 1992;17:1147-1154.
  • 7Villa RF, Arnaboldi R, Ghigini B, et al. Parkinson-like disease by1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in Macaca fascicularis: synaptosomal metabolism and action of dihydroergocriptine. Neurochem Res. 1994;19:229-236.
  • 8Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol. 1995;38:357-366.
  • 9Battino M, Littaru GP, Gorini A, et al. Coenzyme Q, peroxidation and cytochrome oxidase features after Parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria from Macaca fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine. Neurochem Res. 1996;21:1505-1514.
  • 10Bindoff LA, Birch-Machin M, Cartlidge NE, et al. Mitochondrial function in Parkinson’s disease. Lancet. 1989;2:49.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部